{"id":2172,"date":"2018-12-03T20:28:04","date_gmt":"2018-12-03T20:28:04","guid":{"rendered":"https:\/\/medicalcriteria.com\/web\/?p=1389"},"modified":"2026-02-09T18:48:46","modified_gmt":"2026-02-09T18:48:46","slug":"ppis","status":"publish","type":"post","link":"https:\/\/medicalcriteria.com\/web\/es\/ppis\/","title":{"rendered":"Indicaciones Aprobadas para Inhibidores de la Bomba de Protones (IBP)"},"content":{"rendered":"<div class=\"7ca9444b8380138fe077da07353677a4\" data-index=\"1\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script>\r\n<!-- MC 2019- Horizontal -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-0127150553352455\"\r\n     data-ad-slot=\"3806776041\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n<p>Presentados por primera vez en 1989, los inhibidores de la bomba de protones (IBP) se encuentran entre los medicamentos m\u00e1s utilizados en todo el mundo, tanto en entornos cl\u00ednicos ambulatorios como hospitalizados. Los IBP est\u00e1n actualmente aprobados por la Administraci\u00f3n de Alimentos y F\u00e1rmacos (FDA) de EE. UU. para el tratamiento de una variedad de trastornos gastrointestinales, como la \u00falcera p\u00e9ptica sintom\u00e1tica, la enfermedad de reflujo gastroesof\u00e1gico y la dispepsia no ulcerosa, as\u00ed como para la prevenci\u00f3n de hemorragias gastrointestinales en pacientes que reciben terapia antiplaquetaria.<!--more--><\/p>\n<p><strong>Indicaciones Aprobadas para Inhibidores de la Bomba de Protones (IBP)<\/strong><\/p>\n<figure id=\"attachment_1406\" aria-describedby=\"caption-attachment-1406\" style=\"width: 1857px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1406 size-full\" src=\"https:\/\/medicalcriteria.com\/web\/wp-content\/uploads\/2018\/11\/ppi-es.jpg\" alt=\"Indicaciones Aprobadas para Inhibidores de la Bomba de Protones (IBP)\" width=\"1857\" height=\"1485\" \/><figcaption id=\"caption-attachment-1406\" class=\"wp-caption-text\">Indicaciones Aprobadas para Inhibidores de la Bomba de Protones (IBP)<\/figcaption><\/figure>\n<p>AINE, antiinflamatorios no esteroideos; GI, gastrointestinal; IV, intravenoso; NG, nasog\u00e1strico.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Bibliograf\u00eda:<\/strong><\/p>\n<ol>\n<li>Rossi A, Perrella L, Scotti S, Olmastroni E, Galimberti F, Ardoino I, Orlando V, Menditto E, Franchi C, Casula M. Approaches to Deprescribing Proton Pump Inhibitors in Clinical Practice: A Systematic Review. J Clin Med. 2024 Oct 21;13(20):6283. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39458232\/\" target=\"_blank\" rel=\"noopener\">[Medline]<\/a><\/li>\n<li>Strand DS, Kim D, Peura DA. 25 Years of Proton Pump Inhibitors: A Comprehensive Review.\u00a0Gut Liver. 2017 Jan 15;11(1):27-37. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27840364\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<li>Nehra AK, Alexander JA, Loftus CG, Nehra V. Proton Pump Inhibitors: Review of Emerging Concerns.\u00a0Mayo Clin Proc. 2018 Feb;93(2):240-246.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29406201\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>Creado Nov 15, 2018.<br \/>\nActualizado Feb 9, 2026.<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Presentados por primera vez en 1989, los inhibidores de la bomba de protones (IBP) se encuentran entre los medicamentos m\u00e1s utilizados en todo el mundo, tanto en entornos cl\u00ednicos ambulatorios como hospitalizados. Los IBP est\u00e1n actualmente aprobados por la Administraci\u00f3n de Alimentos y F\u00e1rmacos (FDA) de EE. UU. para el tratamiento de una variedad de [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"no","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[53],"tags":[334,339,341,333,74,73,340,337,338,335,342,336],"class_list":["post-2172","post","type-post","status-publish","format-standard","hentry","category-gastroenterology","tag-approved","tag-aprobadas","tag-bomba","tag-ibp","tag-indicaciones","tag-indications","tag-inhibidores","tag-inhibitors","tag-ppis","tag-proton","tag-protones","tag-pump"],"modified_by":"Guillermo Firman","_links":{"self":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/comments?post=2172"}],"version-history":[{"count":4,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2172\/revisions"}],"predecessor-version":[{"id":10643,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2172\/revisions\/10643"}],"wp:attachment":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/media?parent=2172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/categories?post=2172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/tags?post=2172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}